Exploratory Study to Determine the Effect of Lutropin Alfa on Embryo Quality and Their Implantation in Women of Advanced Reproductive Age

Trial Profile

Exploratory Study to Determine the Effect of Lutropin Alfa on Embryo Quality and Their Implantation in Women of Advanced Reproductive Age

Discontinued
Phase of Trial: Phase II

Latest Information Update: 27 Aug 2014

At a glance

  • Drugs Lutropin alfa (Primary) ; Choriogonadotropin alfa; Choriogonadotropin alfa; Gonadotropin releasing hormone; Recombinant follicle-stimulating hormone
  • Indications Infertility
  • Focus Therapeutic Use
  • Sponsors Merck KGaA
  • Most Recent Events

    • 08 Dec 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 30 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 03 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top